Christopher Clough

Insys Therapeutics Inc (NASDAQ: INSY) is a commercial-stage specialty pharmaceutical company whose product Subsys is a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients On Thursday, shares of Insys fell more than 3 percent after the Department of Justice...